Skip to main content

Drug combinatinos for re-writing trajectories of renal pathologies in type II diabetes

EU Flag DC-ren | Medical University Innsbruck

DC-ren has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 848011.